Human plasma fatty acid composition: the features of hyperlipoproteinemia and the influence of -linolenate and clofibrate.
作者信息
Takayasu K, Tada T, Okada F, Yoshikawa I
出版信息
Jpn Circ J. 1971 Sep;35(9):1059-69. doi: 10.1253/jcj.35.1059.
PMID:5172104
Abstract
摘要
相似文献
1
Human plasma fatty acid composition: the features of hyperlipoproteinemia and the influence of -linolenate and clofibrate.
Jpn Circ J. 1971 Sep;35(9):1059-69. doi: 10.1253/jcj.35.1059.
2
Plasma phospholipids in type IV hyperlipoproteinemia.
Atherosclerosis. 1970 Mar-Apr;11(2):265-78. doi: 10.1016/0021-9150(70)90065-1.
3
Changes in the fatty acid composition of plasma lipoproteins during administration of Intralipid to a patient with essential fatty acid deficiency.
Clin Sci Mol Med. 1974 Oct;47(4):387-92. doi: 10.1042/cs0470387.
4
Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
Am J Clin Nutr. 1974 Jan;27(1):22-8. doi: 10.1093/ajcn/27.1.22.
5
[Action of "essential" phospholipids on plasma lipids and fatty acids in type II hyperlipoproteinemias].
Munch Med Wochenschr. 1973 Aug 3;115(31):1358-62.
6
A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
Atherosclerosis. 1972 Jul-Aug;16(1):9-14. doi: 10.1016/0021-9150(72)90003-2.
7
Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol.
Atherosclerosis. 1980 Jan;35(1):51-65. doi: 10.1016/0021-9150(80)90027-1.
8
Plasma phospholipids in the different types of primary hyperlipoproteinemia.
J Lab Clin Med. 1972 Apr;79(4):611-21.
9
[The treatment of essential hyperlipidemia with clofibrate].
Z Gesamte Inn Med. 1969 Jan 1;24(1):Suppl:184-7.
10
Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value.
Ann Intern Med. 1971 Aug;75(2):231-7. doi: 10.7326/0003-4819-75-2-231.
引用本文的文献
1
Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients.
Br J Clin Pharmacol. 1991 Oct;32(4):423-8. doi: 10.1111/j.1365-2125.1991.tb03925.x.
Zotero 插件